How do I buy Danaher (DHR) stock?

Buying Danaher (DHR) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "DHR", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy DHR by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if DHR is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Danaher (DHR) Stock

Q: What is the minimum investment for DHR on Gotrade?

On Gotrade , you don't have to buy a full lot. With fractional shares, you can start investing in Danaher from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · DHR

Trade DHR

Key stats

Market cap: $159.11B
Price / Earnings ratio: 38.2x
EPS (TTM): $6.12
Volume: Loading
52-week high: $242.80
52-week low: $160.93
EPS vs analyst estimate: +9.9%Q3 FY25 · $1.89 vs $1.72

Source: third-party data provider, as of November 7, 2026

EPS estimate: analyst consensus

Compare with DHR

Technical indicators

RSI 14: 49.68
MACD 12/26/9: 3.30
EMA 9 of MACD: 4.02
MACD histogram: -0.72
SMA 50: $219.93; Price above SMA 50
EMA 50: $221.03; Price above EMA 50
SMA 200: $200.95; Price above SMA 200
EMA 200: $210.20; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 9 analyst ratings

Strong Sell0

Sell0

Hold0

Buy9

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

32B21B11B0

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

101B67B33B0

Revenue to Profit

2025

$24.6B

Revenue

$0.0

Cost of revenue

$14.5B

Gross profit

$0.0

Operating expenses

$3.6B

Net income

Earnings

EPS forecast

Actual EPS

$1.89

$1.72

Q3FY25

$2.14

Q4FY25

$2.00

Q1FY26

$1.95

Q2FY26

$1.97

Q3FY26

The market is expecting earnings per share of $1.97 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Danaher

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets.

SectorHealthcare

IndustryDiagnostics & Research

Employees58,000

CEOMs. Julie Sawyer Montgomery

IPO DateJan 5, 1979

HeadquartersWashington, DC

Key Executives

Name	Title	Year Born
Ms. Julie Sawyer Montgomery	President, CEO & Director	1972
Mr. Christopher Paul Riley	Executive VP of Biotechnology Group & CEO of Cytiva	1974
Mr. Steven M. Rales	Co-Founder & Chairman	1951
Mr. Matthew E. Gugino C.F.A., CPA	Executive VP & CFO	1983
Mr. Mitchell P. Rales	Co-Founder & Director	1957
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.	Senior VP & Chief Science Officer	1962
Mr. Matthew R. McGrew	Executive Vice President	1972
Mr. Rainer M. Blair	Senior Advisor	1964
Mr. Christopher M. Bouda	VP & Chief Accounting Officer	—
Ms. Rachel Marie Vatnsdal Olson	Vice President of Investor Relations	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											+6.7	+2.9
2022	-9.5	-4.5	+7.8	-13.9	+5.3	-2.9	+13.0	-6.2	-5.7	-6.4	+6.9	-3.3
2023	+0.8	-7.5	+2.7	-5.3	-5.0	+3.1	+7.7	+3.9	-6.6	-10.2	+17.5	+3.5
2024	+2.2	+3.3	-2.4	-0.5	+4.0	-4.4	+13.3	-4.1	+5.2	-10.5	-3.3	-4.9
2025	-3.1	-3.0	-0.3	-0.5	-3.5	+4.4	-2.0	+4.4	-2.7	+1.2	+5.9	+2.1
2026	-5.0	-5.7	-8.0	-6.2	+4.3	+5.9	+0.7	+8.1	+7.1	+9.7	-0.7

Stocks in the same sector

Labcorp Holdings Inc.

Thermo Fisher Scientific

FAQ

Buying Danaher (DHR) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "DHR", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy DHR by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Danaher from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Yes, Danaher regularly pays dividends to shareholders. Currently, the estimated dividend yield for DHR is around 0.67% per year. On Gotrade, cash dividends will be automatically credited to your account balance (after taxes).

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Danaher (DHR) Stock

Key stats

Compare with DHR

Recent news

Danaher (DHR) Upgraded to Buy: Here's Why

Danaher (DHR) Upgraded to Buy: Here's Why

LH vs. DHR: Which Stock Is the Better Value Option?

LH vs. DHR: Which Stock Is the Better Value Option?

Why Danaher Stock Bounced Higher Today

Why Danaher Stock Bounced Higher Today

Danaher: 3 Key Takeaways for Long-Term Investors

Danaher: 3 Key Takeaways for Long-Term Investors

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Danaher (DHR) Upgraded to Buy: Here's Why

Danaher (DHR) Upgraded to Buy: Here's Why

LH vs. DHR: Which Stock Is the Better Value Option?

LH vs. DHR: Which Stock Is the Better Value Option?

Why Danaher Stock Bounced Higher Today

Why Danaher Stock Bounced Higher Today

Danaher: 3 Key Takeaways for Long-Term Investors

Danaher: 3 Key Takeaways for Long-Term Investors

DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line

DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line

Danaher Q3 Earnings Call Highlights

Danaher Q3 Earnings Call Highlights

Danaher (DHR) Reports Q3 Earnings: What Key Metrics Have to Say

Danaher (DHR) Reports Q3 Earnings: What Key Metrics Have to Say

Medical Giants Thermo Fisher, Danaher Reverse Higher — What Investors Are Seeing

Medical Giants Thermo Fisher, Danaher Reverse Higher — What Investors Are Seeing

Danaher (DHR) Tops Q3 Earnings and Revenue Estimates

Danaher (DHR) Tops Q3 Earnings and Revenue Estimates

Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock?

Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock?

About Danaher

Key Executives

Fundamentals

Valuation

Profitability

Trading

Dividend

Technical indicators

Analyst views

Seasonality

Corporate actions

Upcoming

Past

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade